Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2021-2027

Report Description


The Global Cell Therapy and Tissue Engineering Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Cell Therapy and Tissue Engineering Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Cell Therapy and Tissue Engineering Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Cell Therapy and Tissue Engineering Market product affairs. The report is at risk of project regarding this Cell Therapy and Tissue Engineering Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Betalin Therapeutics
  • BioCardia, Inc
  • BioReliance Corporation
  • Biosolution Co.
  • Brainstorm Cell Therapeutics, Inc
  • MaxCyte, Inc
  • Medigene AG
  • MEDIPOST CO.
  • Mesoblast Limited
  • Miromatrix Medical, Inc.
  • MolMed S.p.A
  • Mustang Bio, Inc
  • NantKwest, Inc.
  • Neuralstem, Inc
  • NexImmune, Inc.
  • Nohla Therapeutics, Inc
  • ReNeuron Group plc
  • Richter-Helm BioLogics GmbH & Co. KG
  • RoosterBio, Inc
  • RoslinCT
  • Rubius Therapeutics, Inc.
  • Sangamo Therapeutics, Inc
  • Voyager Therapeutics, Inc
  • Waisman Biomanufacturing
  • WindMIL Therapeutics, Inc.
  • Wuxi App Tec, Inc.
  • ReNeuron Group plc
  • Richter-Helm BioLogics GmbH & Co. KG
  • RoosterBio, Inc
  • RoslinCT

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Cell Therapy and Tissue Engineering related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Cell Therapy and Tissue Engineering Market

Cell Therapy and Tissue Engineering Market

Report Highlights:


The Cell Therapy and Tissue Engineering Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Cell Therapy and Tissue Engineering Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Cell Therapy and Tissue Engineering Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Cell Therapy and Tissue Engineering Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Cell Therapy and Tissue Engineering marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Cell Therapy and Tissue Engineering market using a bottom-up approach, wherein manufacturers value data for different type (Cell Therapy, Tissue Engineering), of Cell Therapy and Tissue Engineering market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Cell Therapy and Tissue Engineering Market

Cell Therapy and Tissue Engineering Market

Key Target Audience:


  • Cell Therapy and Tissue Engineering market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Cell Therapy and Tissue Engineering market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Cell Therapy and Tissue Engineering market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Cell Therapy and Tissue Engineering market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Cell Therapy
  • Tissue Engineering

By end-user also classify into, the Global Cell Therapy and Tissue Engineering market:


Global Cell Therapy and Tissue Engineering market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Cell Defects
  • Genetic Diseases
  • Neurodegenerative Diseases
  • Tissue Malignancies
  • Others

Highlights of this 2021-2027 Cell Therapy and Tissue Engineering Market Report:

  • Market dynamics, Cell Therapy and Tissue Engineering economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Cell Therapy and Tissue Engineering industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Cell Therapy and Tissue Engineering Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Cell Therapy and Tissue Engineering businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Cell Therapy and Tissue Engineering market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1ReportOverview
1.1StudyScope
1.2KeyMarketSegments
1.3PlayersCovered:RankingbyCellTherapyandTissueEngineeringRevenue
1.4MarketAnalysisbyType
1.4.1GlobalCellTherapyandTissueEngineeringMarketSizeGrowthRatebyType:2021VS2027
1.4.2CellTherapy
1.4.3TissueEngineering
1.5MarketbyApplication
1.5.1GlobalCellTherapyandTissueEngineeringMarketSharebyApplication:2021VS2027
1.5.2CellDefects
1.5.3GeneticDiseases
1.5.4NeurodegenerativeDiseases
1.5.5TissueMalignancies
1.5.6Others 1.6StudyObjectives 1.7YearsConsidered 2GlobalGrowthTrendsbyRegions
2.1CellTherapyandTissueEngineeringMarketPerspective(2016-2027)
2.2CellTherapyandTissueEngineeringGrowthTrendsbyRegions
2.2.1CellTherapyandTissueEngineeringMarketSizebyRegions:2016VS2021VS2027
2.2.2CellTherapyandTissueEngineeringHistoricMarketSharebyRegions(2016-2021)
2.2.3CellTherapyandTissueEngineeringForecastedMarketSizebyRegions(2021-2027) 2.3IndustryTrendsandGrowthStrategy 2.3.1MarketTopTrends 2.3.2MarketDrivers
2.3.3MarketChallenges
2.3.4PortersFiveForcesAnalysis
2.3.5CellTherapyandTissueEngineeringMarketGrowthStrategy
2.3.6PrimaryInterviewswithKeyCellTherapyandTissueEngineeringPlayers(OpinionLeaders) 3CompetitionLandscapebyKeyPlayers
3.1GlobalTopCellTherapyandTissueEngineeringPlayersbyMarketSize
3.1.1GlobalTopCellTherapyandTissueEngineeringPlayersbyRevenue(2016-2021)
3.1.2GlobalCellTherapyandTissueEngineeringRevenueMarketSharebyPlayers(2016-2021)
3.1.3GlobalCellTherapyandTissueEngineeringMarketSharebyCompanyType(Tier1,Tier2andTier3)
3.2GlobalCellTherapyandTissueEngineeringMarketConcentrationRatio
3.2.1GlobalCellTherapyandTissueEngineeringMarketConcentrationRatio(CR5andHHI)
3.2.2GlobalTop10andTop5CompaniesbyCellTherapyandTissueEngineeringRevenuein2020
3.3CellTherapyandTissueEngineeringKeyPlayersHeadofficeandAreaServed
3.4KeyPlayersCellTherapyandTissueEngineeringProductSolutionandService
3.5DateofEnterintoCellTherapyandTissueEngineeringMarket
3.6Mergers&Acquisitions,ExpansionPlans 4BreakdownDatabyType(2016-2027)
4.1GlobalCellTherapyandTissueEngineeringHistoricMarketSizebyType(2016-2021)
4.2GlobalCellTherapyandTissueEngineeringForecastedMarketSizebyType(2021-2027) 5CellTherapyandTissueEngineeringBreakdownDatabyApplication(2016-2027)
5.1GlobalCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021)
5.2GlobalCellTherapyandTissueEngineeringForecastedMarketSizebyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaCellTherapyandTissueEngineeringMarketSize(2016-2021)
6.2CellTherapyandTissueEngineeringKeyPlayersinNorthAmerica(2020-2021)
6.3NorthAmericaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
6.4NorthAmericaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 7Europe
7.1EuropeCellTherapyandTissueEngineeringMarketSize(2016-2021)
7.2CellTherapyandTissueEngineeringKeyPlayersinEurope(2020-2021)
7.3EuropeCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
7.4EuropeCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 8China
8.1ChinaCellTherapyandTissueEngineeringMarketSize(2016-2021)
8.2CellTherapyandTissueEngineeringKeyPlayersinChina(2020-2021)
8.3ChinaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
8.4ChinaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 9Japan
9.1JapanCellTherapyandTissueEngineeringMarketSize(2016-2021)
9.2CellTherapyandTissueEngineeringKeyPlayersinJapan(2020-2021)
9.3JapanCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
9.4JapanCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 10SoutheastAsia
10.1SoutheastAsiaCellTherapyandTissueEngineeringMarketSize(2016-2021)
10.2CellTherapyandTissueEngineeringKeyPlayersinSoutheastAsia(2020-2021)
10.3SoutheastAsiaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
10.4SoutheastAsiaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 11India
11.1IndiaCellTherapyandTissueEngineeringMarketSize(2016-2021)
11.2CellTherapyandTissueEngineeringKeyPlayersinIndia(2020-2021)
11.3IndiaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
11.4IndiaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 12Central&SouthAmerica
12.1Central&SouthAmericaCellTherapyandTissueEngineeringMarketSize(2016-2021)
12.2CellTherapyandTissueEngineeringKeyPlayersinCentral&SouthAmerica(2020-2021)
12.3Central&SouthAmericaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
12.4Central&SouthAmericaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 13KeyPlayersProfiles
13.1BetalinTherapeutics
13.1.1BetalinTherapeuticsCompanyDetails
13.1.2BetalinTherapeuticsBusinessOverviewandItsTotalRevenue
13.1.3BetalinTherapeuticsCellTherapyandTissueEngineeringIntroduction
13.1.4BetalinTherapeuticsRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021))
13.1.5BetalinTherapeuticsRecentDevelopment
13.2BioCardia,Inc
13.2.1BioCardia,IncCompanyDetails
13.2.2BioCardia,IncBusinessOverviewandItsTotalRevenue
13.2.3BioCardia,IncCellTherapyandTissueEngineeringIntroduction
13.2.4BioCardia,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.2.5BioCardia,IncRecentDevelopment
13.3BioRelianceCorporation
13.3.1BioRelianceCorporationCompanyDetails
13.3.2BioRelianceCorporationBusinessOverviewandItsTotalRevenue
13.3.3BioRelianceCorporationCellTherapyandTissueEngineeringIntroduction
13.3.4BioRelianceCorporationRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.3.5BioRelianceCorporationRecentDevelopment
13.4BiosolutionCo.
13.4.1BiosolutionCo.CompanyDetails
13.4.2BiosolutionCo.BusinessOverviewandItsTotalRevenue
13.4.3BiosolutionCo.CellTherapyandTissueEngineeringIntroduction
13.4.4BiosolutionCo.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.4.5BiosolutionCo.RecentDevelopment
13.5BrainstormCellTherapeutics,Inc
13.5.1BrainstormCellTherapeutics,IncCompanyDetails
13.5.2BrainstormCellTherapeutics,IncBusinessOverviewandItsTotalRevenue
13.5.3BrainstormCellTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
13.5.4BrainstormCellTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.5.5BrainstormCellTherapeutics,IncRecentDevelopment
13.6MaxCyte,Inc
13.6.1MaxCyte,IncCompanyDetails
13.6.2MaxCyte,IncBusinessOverviewandItsTotalRevenue
13.6.3MaxCyte,IncCellTherapyandTissueEngineeringIntroduction
13.6.4MaxCyte,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.6.5MaxCyte,IncRecentDevelopment
13.7MedigeneAG
13.7.1MedigeneAGCompanyDetails
13.7.2MedigeneAGBusinessOverviewandItsTotalRevenue
13.7.3MedigeneAGCellTherapyandTissueEngineeringIntroduction
13.7.4MedigeneAGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.7.5MedigeneAGRecentDevelopment
13.8MEDIPOSTCO.
13.8.1MEDIPOSTCO.CompanyDetails
13.8.2MEDIPOSTCO.BusinessOverviewandItsTotalRevenue
13.8.3MEDIPOSTCO.CellTherapyandTissueEngineeringIntroduction
13.8.4MEDIPOSTCO.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.8.5MEDIPOSTCO.RecentDevelopment
13.9MesoblastLimited
13.9.1MesoblastLimitedCompanyDetails
13.9.2MesoblastLimitedBusinessOverviewandItsTotalRevenue
13.9.3MesoblastLimitedCellTherapyandTissueEngineeringIntroduction
13.9.4MesoblastLimitedRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.9.5MesoblastLimitedRecentDevelopment
13.10MiromatrixMedical,Inc.
13.10.1MiromatrixMedical,Inc.CompanyDetails
13.10.2MiromatrixMedical,Inc.BusinessOverviewandItsTotalRevenue
13.10.3MiromatrixMedical,Inc.CellTherapyandTissueEngineeringIntroduction
13.10.4MiromatrixMedical,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.10.5MiromatrixMedical,Inc.RecentDevelopment
13.11MolMedS.p.A
10.11.1MolMedS.p.ACompanyDetails
10.11.2MolMedS.p.ABusinessOverviewandItsTotalRevenue
10.11.3MolMedS.p.ACellTherapyandTissueEngineeringIntroduction
10.11.4MolMedS.p.ARevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.11.5MolMedS.p.ARecentDevelopment
13.12MustangBio,Inc
10.12.1MustangBio,IncCompanyDetails
10.12.2MustangBio,IncBusinessOverviewandItsTotalRevenue
10.12.3MustangBio,IncCellTherapyandTissueEngineeringIntroduction
10.12.4MustangBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.12.5MustangBio,IncRecentDevelopment
13.13NantKwest,Inc.
10.13.1NantKwest,Inc.CompanyDetails
10.13.2NantKwest,Inc.BusinessOverviewandItsTotalRevenue
10.13.3NantKwest,Inc.CellTherapyandTissueEngineeringIntroduction
10.13.4NantKwest,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.13.5NantKwest,Inc.RecentDevelopment
13.14Neuralstem,Inc
10.14.1Neuralstem,IncCompanyDetails
10.14.2Neuralstem,IncBusinessOverviewandItsTotalRevenue
10.14.3Neuralstem,IncCellTherapyandTissueEngineeringIntroduction
10.14.4Neuralstem,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.14.5Neuralstem,IncRecentDevelopment
13.15NexImmune,Inc.
10.15.1NexImmune,Inc.CompanyDetails
10.15.2NexImmune,Inc.BusinessOverviewandItsTotalRevenue
10.15.3NexImmune,Inc.CellTherapyandTissueEngineeringIntroduction
10.15.4NexImmune,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.15.5NexImmune,Inc.RecentDevelopment
13.16NohlaTherapeutics,Inc
10.16.1NohlaTherapeutics,IncCompanyDetails
10.16.2NohlaTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.16.3NohlaTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.16.4NohlaTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.16.5NohlaTherapeutics,IncRecentDevelopment
13.17ReNeuronGroupplc
10.17.1ReNeuronGroupplcCompanyDetails
10.17.2ReNeuronGroupplcBusinessOverviewandItsTotalRevenue
10.17.3ReNeuronGroupplcCellTherapyandTissueEngineeringIntroduction
10.17.4ReNeuronGroupplcRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.17.5ReNeuronGroupplcRecentDevelopment
13.18Richter-HelmBioLogicsGmbH&Co.KG
10.18.1Richter-HelmBioLogicsGmbH&Co.KGCompanyDetails
10.18.2Richter-HelmBioLogicsGmbH&Co.KGBusinessOverviewandItsTotalRevenue
10.18.3Richter-HelmBioLogicsGmbH&Co.KGCellTherapyandTissueEngineeringIntroduction
10.18.4Richter-HelmBioLogicsGmbH&Co.KGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.18.5Richter-HelmBioLogicsGmbH&Co.KGRecentDevelopment
13.19RoosterBio,Inc
10.19.1RoosterBio,IncCompanyDetails
10.19.2RoosterBio,IncBusinessOverviewandItsTotalRevenue
10.19.3RoosterBio,IncCellTherapyandTissueEngineeringIntroduction
10.19.4RoosterBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.19.5RoosterBio,IncRecentDevelopment
13.20RoslinCT
10.20.1RoslinCTCompanyDetails
10.20.2RoslinCTBusinessOverviewandItsTotalRevenue
10.20.3RoslinCTCellTherapyandTissueEngineeringIntroduction
10.20.4RoslinCTRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.20.5RoslinCTRecentDevelopment
13.21RubiusTherapeutics,Inc.
10.21.1RubiusTherapeutics,Inc.CompanyDetails
10.21.2RubiusTherapeutics,Inc.BusinessOverviewandItsTotalRevenue
10.21.3RubiusTherapeutics,Inc.CellTherapyandTissueEngineeringIntroduction
10.21.4RubiusTherapeutics,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.21.5RubiusTherapeutics,Inc.RecentDevelopment
13.22SangamoTherapeutics,Inc
10.22.1SangamoTherapeutics,IncCompanyDetails
10.22.2SangamoTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.22.3SangamoTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.22.4SangamoTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.22.5SangamoTherapeutics,IncRecentDevelopment
13.23VoyagerTherapeutics,Inc
10.23.1VoyagerTherapeutics,IncCompanyDetails
10.23.2VoyagerTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.23.3VoyagerTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.23.4VoyagerTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.23.5VoyagerTherapeutics,IncRecentDevelopment
13.24WaismanBiomanufacturing
10.24.1WaismanBiomanufacturingCompanyDetails
10.24.2WaismanBiomanufacturingBusinessOverviewandItsTotalRevenue
10.24.3WaismanBiomanufacturingCellTherapyandTissueEngineeringIntroduction
10.24.4WaismanBiomanufacturingRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.24.5WaismanBiomanufacturingRecentDevelopment
13.25WindMILTherapeutics,Inc.
10.25.1WindMILTherapeutics,Inc.CompanyDetails
10.25.2WindMILTherapeutics,Inc.BusinessOverviewandItsTotalRevenue
10.25.3WindMILTherapeutics,Inc.CellTherapyandTissueEngineeringIntroduction
10.25.4WindMILTherapeutics,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.25.5WindMILTherapeutics,Inc.RecentDevelopment
13.26WuxiAppTec,Inc.
10.26.1WuxiAppTec,Inc.CompanyDetails
10.26.2WuxiAppTec,Inc.BusinessOverviewandItsTotalRevenue
10.26.3WuxiAppTec,Inc.CellTherapyandTissueEngineeringIntroduction
10.26.4WuxiAppTec,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.26.5WuxiAppTec,Inc.RecentDevelopment
13.27ReNeuronGroupplc
10.27.1ReNeuronGroupplcCompanyDetails
10.27.2ReNeuronGroupplcBusinessOverviewandItsTotalRevenue
10.27.3ReNeuronGroupplcCellTherapyandTissueEngineeringIntroduction
10.27.4ReNeuronGroupplcRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.27.5ReNeuronGroupplcRecentDevelopment
13.28Richter-HelmBioLogicsGmbH&Co.KG
10.28.1Richter-HelmBioLogicsGmbH&Co.KGCompanyDetails
10.28.2Richter-HelmBioLogicsGmbH&Co.KGBusinessOverviewandItsTotalRevenue
10.28.3Richter-HelmBioLogicsGmbH&Co.KGCellTherapyandTissueEngineeringIntroduction
10.28.4Richter-HelmBioLogicsGmbH&Co.KGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.28.5Richter-HelmBioLogicsGmbH&Co.KGRecentDevelopment
13.29RoosterBio,Inc
10.29.1RoosterBio,IncCompanyDetails
10.29.2RoosterBio,IncBusinessOverviewandItsTotalRevenue
10.29.3RoosterBio,IncCellTherapyandTissueEngineeringIntroduction
10.29.4RoosterBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.29.5RoosterBio,IncRecentDevelopment
13.30RoslinCT
10.30.1RoslinCTCompanyDetails
10.30.2RoslinCTBusinessOverviewandItsTotalRevenue
10.30.3RoslinCTCellTherapyandTissueEngineeringIntroduction
10.30.4RoslinCTRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.30.5RoslinCTRecentDevelopment 14Analyst'sViewpoints/Conclusions 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2Disclaimer
15.3AuthorDetails

List of Tables
Table 1. Cell Therapy and Tissue Engineering Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
Table 3. Ranking of Global Top Cell Therapy and Tissue Engineering Manufacturers by Revenue (US$ Million) in 2020
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 8. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2021 VS 2027
Table 9. Global Cell Therapy and Tissue Engineering Market Size by Regions (2016-2021) (US$ Million)
Table 10. Global Cell Therapy and Tissue Engineering Market Share by Regions (2016-2021)
Table 11. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 12. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2027)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cell Therapy and Tissue Engineering Market Growth Strategy
Table 17. Main Points Interviewed from Key Cell Therapy and Tissue Engineering Players
Table 18. Global Cell Therapy and Tissue Engineering Revenue by Players (2016-2021) (Million US$)
Table 19. Global Cell Therapy and Tissue Engineering Market Share by Players (2016-2021)
Table 20. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020)
Table 21. Global Cell Therapy and Tissue Engineering by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell Therapy and Tissue Engineering Product Solution and Service
Table 24. Date of Enter into Cell Therapy and Tissue Engineering Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2016-2021)
Table 28. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2021-2027)
Table 29. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2016-2021)
Table 30. Global Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 31. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2021-2027)
Table 32. North America Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 33. North America Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 34. North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 35. North America Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 36. North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 37. North America Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 38. Europe Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 39. Europe Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 41. Europe Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 42. Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 43. Europe Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 44. China Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 45. China Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 47. China Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 49. China Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 50. Japan Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 51. Japan Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 52. Japan Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 53. Japan Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 54. Japan Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 55. Japan Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 56. Southeast Asia Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 57. Southeast Asia Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 58. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 59. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 60. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 61. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 62. India Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 63. India Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 64. India Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 65. India Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 66. India Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 67. India Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 68. Central & South America Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 69. Central & South America Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 70. Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 71. Central & South America Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 72. Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 73. Central & South America Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 74. Betalin Therapeutics Company Details
Table 75. Betalin Therapeutics Business Overview
Table 76. Betalin Therapeutics Product
Table 77. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 78. Betalin Therapeutics Recent Development
Table 79. BioCardia, Inc Company Details
Table 80. BioCardia, Inc Business Overview
Table 81. BioCardia, Inc Product
Table 82. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 83. BioCardia, Inc Recent Development
Table 84. BioReliance Corporation Company Details
Table 85. BioReliance Corporation Business Overview
Table 86. BioReliance Corporation Product
Table 87. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 88. BioReliance Corporation Recent Development
Table 89. Biosolution Co. Company Details
Table 90. Biosolution Co. Business Overview
Table 91. Biosolution Co. Product
Table 92. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 93. Biosolution Co. Recent Development
Table 94. Brainstorm Cell Therapeutics, Inc Company Details
Table 95. Brainstorm Cell Therapeutics, Inc Business Overview
Table 96. Brainstorm Cell Therapeutics, Inc Product
Table 97. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 98. Brainstorm Cell Therapeutics, Inc Recent Development
Table 99. MaxCyte, Inc Company Details
Table 100. MaxCyte, Inc Business Overview
Table 101. MaxCyte, Inc Product
Table 102. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 103. MaxCyte, Inc Recent Development
Table 104. Medigene AG Company Details
Table 105. Medigene AG Business Overview
Table 106. Medigene AG Product
Table 107. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 108. Medigene AG Recent Development
Table 109. MEDIPOST CO. Business Overview
Table 110. MEDIPOST CO. Product
Table 111. MEDIPOST CO. Company Details
Table 112. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 113. MEDIPOST CO. Recent Development
Table 114. Mesoblast Limited Company Details
Table 115. Mesoblast Limited Business Overview
Table 116. Mesoblast Limited Product
Table 117. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 118. Mesoblast Limited Recent Development
Table 119. Miromatrix Medical, Inc. Company Details
Table 120. Miromatrix Medical, Inc. Business Overview
Table 121. Miromatrix Medical, Inc. Product
Table 122. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 123. Miromatrix Medical, Inc. Recent Development
Table 124. MolMed S.p.A Company Details
Table 125. MolMed S.p.A Business Overview
Table 126. MolMed S.p.A Product
Table 127. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 128. MolMed S.p.A Recent Development
Table 129. Mustang Bio, Inc Company Details
Table 130. Mustang Bio, Inc Business Overview
Table 131. Mustang Bio, Inc Product
Table 132. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 133. Mustang Bio, Inc Recent Development
Table 134. NantKwest, Inc. Company Details
Table 135. NantKwest, Inc. Business Overview
Table 136. NantKwest, Inc. Product
Table 137. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 138. NantKwest, Inc. Recent Development
Table 139. Neuralstem, Inc Company Details
Table 140. Neuralstem, Inc Business Overview
Table 141. Neuralstem, Inc Product
Table 142. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 143. Neuralstem, Inc Recent Development
Table 144. NexImmune, Inc. Company Details
Table 145. NexImmune, Inc. Business Overview
Table 146. NexImmune, Inc. Product
Table 147. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 148. NexImmune, Inc. Recent Development
Table 149. Nohla Therapeutics, Inc Company Details
Table 150. Nohla Therapeutics, Inc Business Overview
Table 151. Nohla Therapeutics, Inc Product
Table 152. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 153. Nohla Therapeutics, Inc Recent Development
Table 154. ReNeuron Group plc Company Details
Table 155. ReNeuron Group plc Business Overview
Table 156. ReNeuron Group plc Product
Table 157. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 158. ReNeuron Group plc Recent Development
Table 159. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 160. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 161. Richter-Helm BioLogics GmbH & Co. KG Product
Table 162. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 163. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 164. RoosterBio, Inc Company Details
Table 165. RoosterBio, Inc Business Overview
Table 166. RoosterBio, Inc Product
Table 167. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 168. RoosterBio, Inc Recent Development
Table 169. RoslinCT Company Details
Table 170. RoslinCT Business Overview
Table 171. RoslinCT Product
Table 172. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 173. RoslinCT Recent Development
Table 174. Rubius Therapeutics, Inc. Company Details
Table 175. Rubius Therapeutics, Inc. Business Overview
Table 176. Rubius Therapeutics, Inc. Product
Table 177. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 178. Rubius Therapeutics, Inc. Recent Development
Table 179. Sangamo Therapeutics, Inc Company Details
Table 180. Sangamo Therapeutics, Inc Business Overview
Table 181. Sangamo Therapeutics, Inc Product
Table 182. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 183. Sangamo Therapeutics, Inc Recent Development
Table 184. Voyager Therapeutics, Inc Company Details
Table 185. Voyager Therapeutics, Inc Business Overview
Table 186. Voyager Therapeutics, Inc Product
Table 187. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 188. Voyager Therapeutics, Inc Recent Development
Table 189. Waisman Biomanufacturing Company Details
Table 190. Waisman Biomanufacturing Business Overview
Table 191. Waisman Biomanufacturing Product
Table 192. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 193. Waisman Biomanufacturing Recent Development
Table 194. WindMIL Therapeutics, Inc. Company Details
Table 195. WindMIL Therapeutics, Inc. Business Overview
Table 196. WindMIL Therapeutics, Inc. Product
Table 197. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 198. WindMIL Therapeutics, Inc. Recent Development
Table 199. Wuxi App Tec, Inc. Company Details
Table 200. Wuxi App Tec, Inc. Business Overview
Table 201. Wuxi App Tec, Inc. Product
Table 202. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 203. Wuxi App Tec, Inc. Recent Development
Table 204. ReNeuron Group plc Company Details
Table 205. ReNeuron Group plc Business Overview
Table 206. ReNeuron Group plc Product
Table 207. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 208. ReNeuron Group plc Recent Development
Table 209. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 210. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 211. Richter-Helm BioLogics GmbH & Co. KG Product
Table 212. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 213. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 214. RoosterBio, Inc Company Details
Table 215. RoosterBio, Inc Business Overview
Table 216. RoosterBio, Inc Product
Table 217. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 218. RoosterBio, Inc Recent Development
Table 219. RoslinCT Company Details
Table 220. RoslinCT Business Overview
Table 221. RoslinCT Product
Table 222. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 223. RoslinCT Recent Development
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2021 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2021 VS 2027
Figure 5. Cell Defects Case Studies
Figure 6. Genetic Diseases Case Studies
Figure 7. Neurodegenerative Diseases Case Studies
Figure 8. Tissue Malignancies Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy and Tissue Engineering Report Years Considered
Figure 11. Global Cell Therapy and Tissue Engineering Market Size YoY Growth 2016-2027 (US$ Million)
Figure 12. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2021 VS 2027
Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2027)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2020
Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2020
Figure 18. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 19. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 20. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 21. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 22. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 23. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 24. Central & South America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 25. Betalin Therapeutics Total Revenue (US$ Million): 2020 Compared with 2018
Figure 26. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 27. BioCardia, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 28. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 29. BioReliance Corporation Total Revenue (US$ Million): 2020 Compared with 2018
Figure 30. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 31. Biosolution Co. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 32. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 33. Brainstorm Cell Therapeutics, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 34. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 35. MaxCyte, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 36. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 37. Medigene AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 38. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 39. MEDIPOST CO. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 40. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 41. Mesoblast Limited Total Revenue (US$ Million): 2020 Compared with 2018
Figure 42. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 43. Miromatrix Medical, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 44. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 45. MolMed S.p.A Total Revenue (US$ Million): 2020 Compared with 2018
Figure 46. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 47. Mustang Bio, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 48. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 49. NantKwest, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 50. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 51. Neuralstem, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 52. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 53. NexImmune, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 54. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 55. Nohla Therapeutics, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 56. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 57. ReNeuron Group plc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 58. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 59. Richter-Helm BioLogics GmbH & Co. KG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 60. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 61. RoosterBio, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 63. RoslinCT Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Cell Therapy and Tissue Engineering Market Segments


Cell Therapy and Tissue Engineering Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Cell Therapy
  • Tissue Engineering

Cell Therapy and Tissue Engineering Application Outlook (Revenue, USD Million, 2021 2027)


  • Cell Defects
  • Genetic Diseases
  • Neurodegenerative Diseases
  • Tissue Malignancies
  • Others

Cell Therapy and Tissue Engineering Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Europe
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Asia Pacific
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Latin America
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Middle East & Africa
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Cell Therapy and Tissue Engineering Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Cell Therapy and Tissue Engineering Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Cell Therapy and Tissue Engineering Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Cell Therapy and Tissue Engineering Market product affairs. The report is at risk of project regarding this Cell Therapy and Tissue Engineering Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Betalin Therapeutics
  • BioCardia, Inc
  • BioReliance Corporation
  • Biosolution Co.
  • Brainstorm Cell Therapeutics, Inc
  • MaxCyte, Inc
  • Medigene AG
  • MEDIPOST CO.
  • Mesoblast Limited
  • Miromatrix Medical, Inc.
  • MolMed S.p.A
  • Mustang Bio, Inc
  • NantKwest, Inc.
  • Neuralstem, Inc
  • NexImmune, Inc.
  • Nohla Therapeutics, Inc
  • ReNeuron Group plc
  • Richter-Helm BioLogics GmbH & Co. KG
  • RoosterBio, Inc
  • RoslinCT
  • Rubius Therapeutics, Inc.
  • Sangamo Therapeutics, Inc
  • Voyager Therapeutics, Inc
  • Waisman Biomanufacturing
  • WindMIL Therapeutics, Inc.
  • Wuxi App Tec, Inc.
  • ReNeuron Group plc
  • Richter-Helm BioLogics GmbH & Co. KG
  • RoosterBio, Inc
  • RoslinCT

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Cell Therapy and Tissue Engineering related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Cell Therapy and Tissue Engineering Market

Cell Therapy and Tissue Engineering Market

Report Highlights:


The Cell Therapy and Tissue Engineering Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Cell Therapy and Tissue Engineering Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Cell Therapy and Tissue Engineering Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Cell Therapy and Tissue Engineering Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Cell Therapy and Tissue Engineering marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Cell Therapy and Tissue Engineering market using a bottom-up approach, wherein manufacturers value data for different type (Cell Therapy, Tissue Engineering), of Cell Therapy and Tissue Engineering market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Cell Therapy and Tissue Engineering Market

Cell Therapy and Tissue Engineering Market

Key Target Audience:


  • Cell Therapy and Tissue Engineering market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Cell Therapy and Tissue Engineering market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Cell Therapy and Tissue Engineering market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Cell Therapy and Tissue Engineering market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Cell Therapy
  • Tissue Engineering

By end-user also classify into, the Global Cell Therapy and Tissue Engineering market:


Global Cell Therapy and Tissue Engineering market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Cell Defects
  • Genetic Diseases
  • Neurodegenerative Diseases
  • Tissue Malignancies
  • Others

Highlights of this 2021-2027 Cell Therapy and Tissue Engineering Market Report:

  • Market dynamics, Cell Therapy and Tissue Engineering economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Cell Therapy and Tissue Engineering industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Cell Therapy and Tissue Engineering Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Cell Therapy and Tissue Engineering businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Cell Therapy and Tissue Engineering market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
TableofContents 1ReportOverview
1.1StudyScope
1.2KeyMarketSegments
1.3PlayersCovered:RankingbyCellTherapyandTissueEngineeringRevenue
1.4MarketAnalysisbyType
1.4.1GlobalCellTherapyandTissueEngineeringMarketSizeGrowthRatebyType:2021VS2027
1.4.2CellTherapy
1.4.3TissueEngineering
1.5MarketbyApplication
1.5.1GlobalCellTherapyandTissueEngineeringMarketSharebyApplication:2021VS2027
1.5.2CellDefects
1.5.3GeneticDiseases
1.5.4NeurodegenerativeDiseases
1.5.5TissueMalignancies
1.5.6Others 1.6StudyObjectives 1.7YearsConsidered 2GlobalGrowthTrendsbyRegions
2.1CellTherapyandTissueEngineeringMarketPerspective(2016-2027)
2.2CellTherapyandTissueEngineeringGrowthTrendsbyRegions
2.2.1CellTherapyandTissueEngineeringMarketSizebyRegions:2016VS2021VS2027
2.2.2CellTherapyandTissueEngineeringHistoricMarketSharebyRegions(2016-2021)
2.2.3CellTherapyandTissueEngineeringForecastedMarketSizebyRegions(2021-2027) 2.3IndustryTrendsandGrowthStrategy 2.3.1MarketTopTrends 2.3.2MarketDrivers
2.3.3MarketChallenges
2.3.4PortersFiveForcesAnalysis
2.3.5CellTherapyandTissueEngineeringMarketGrowthStrategy
2.3.6PrimaryInterviewswithKeyCellTherapyandTissueEngineeringPlayers(OpinionLeaders) 3CompetitionLandscapebyKeyPlayers
3.1GlobalTopCellTherapyandTissueEngineeringPlayersbyMarketSize
3.1.1GlobalTopCellTherapyandTissueEngineeringPlayersbyRevenue(2016-2021)
3.1.2GlobalCellTherapyandTissueEngineeringRevenueMarketSharebyPlayers(2016-2021)
3.1.3GlobalCellTherapyandTissueEngineeringMarketSharebyCompanyType(Tier1,Tier2andTier3)
3.2GlobalCellTherapyandTissueEngineeringMarketConcentrationRatio
3.2.1GlobalCellTherapyandTissueEngineeringMarketConcentrationRatio(CR5andHHI)
3.2.2GlobalTop10andTop5CompaniesbyCellTherapyandTissueEngineeringRevenuein2020
3.3CellTherapyandTissueEngineeringKeyPlayersHeadofficeandAreaServed
3.4KeyPlayersCellTherapyandTissueEngineeringProductSolutionandService
3.5DateofEnterintoCellTherapyandTissueEngineeringMarket
3.6Mergers&Acquisitions,ExpansionPlans 4BreakdownDatabyType(2016-2027)
4.1GlobalCellTherapyandTissueEngineeringHistoricMarketSizebyType(2016-2021)
4.2GlobalCellTherapyandTissueEngineeringForecastedMarketSizebyType(2021-2027) 5CellTherapyandTissueEngineeringBreakdownDatabyApplication(2016-2027)
5.1GlobalCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021)
5.2GlobalCellTherapyandTissueEngineeringForecastedMarketSizebyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaCellTherapyandTissueEngineeringMarketSize(2016-2021)
6.2CellTherapyandTissueEngineeringKeyPlayersinNorthAmerica(2020-2021)
6.3NorthAmericaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
6.4NorthAmericaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 7Europe
7.1EuropeCellTherapyandTissueEngineeringMarketSize(2016-2021)
7.2CellTherapyandTissueEngineeringKeyPlayersinEurope(2020-2021)
7.3EuropeCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
7.4EuropeCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 8China
8.1ChinaCellTherapyandTissueEngineeringMarketSize(2016-2021)
8.2CellTherapyandTissueEngineeringKeyPlayersinChina(2020-2021)
8.3ChinaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
8.4ChinaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 9Japan
9.1JapanCellTherapyandTissueEngineeringMarketSize(2016-2021)
9.2CellTherapyandTissueEngineeringKeyPlayersinJapan(2020-2021)
9.3JapanCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
9.4JapanCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 10SoutheastAsia
10.1SoutheastAsiaCellTherapyandTissueEngineeringMarketSize(2016-2021)
10.2CellTherapyandTissueEngineeringKeyPlayersinSoutheastAsia(2020-2021)
10.3SoutheastAsiaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
10.4SoutheastAsiaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 11India
11.1IndiaCellTherapyandTissueEngineeringMarketSize(2016-2021)
11.2CellTherapyandTissueEngineeringKeyPlayersinIndia(2020-2021)
11.3IndiaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
11.4IndiaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 12Central&SouthAmerica
12.1Central&SouthAmericaCellTherapyandTissueEngineeringMarketSize(2016-2021)
12.2CellTherapyandTissueEngineeringKeyPlayersinCentral&SouthAmerica(2020-2021)
12.3Central&SouthAmericaCellTherapyandTissueEngineeringMarketSizebyType(2016-2021)
12.4Central&SouthAmericaCellTherapyandTissueEngineeringMarketSizebyApplication(2016-2021) 13KeyPlayersProfiles
13.1BetalinTherapeutics
13.1.1BetalinTherapeuticsCompanyDetails
13.1.2BetalinTherapeuticsBusinessOverviewandItsTotalRevenue
13.1.3BetalinTherapeuticsCellTherapyandTissueEngineeringIntroduction
13.1.4BetalinTherapeuticsRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021))
13.1.5BetalinTherapeuticsRecentDevelopment
13.2BioCardia,Inc
13.2.1BioCardia,IncCompanyDetails
13.2.2BioCardia,IncBusinessOverviewandItsTotalRevenue
13.2.3BioCardia,IncCellTherapyandTissueEngineeringIntroduction
13.2.4BioCardia,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.2.5BioCardia,IncRecentDevelopment
13.3BioRelianceCorporation
13.3.1BioRelianceCorporationCompanyDetails
13.3.2BioRelianceCorporationBusinessOverviewandItsTotalRevenue
13.3.3BioRelianceCorporationCellTherapyandTissueEngineeringIntroduction
13.3.4BioRelianceCorporationRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.3.5BioRelianceCorporationRecentDevelopment
13.4BiosolutionCo.
13.4.1BiosolutionCo.CompanyDetails
13.4.2BiosolutionCo.BusinessOverviewandItsTotalRevenue
13.4.3BiosolutionCo.CellTherapyandTissueEngineeringIntroduction
13.4.4BiosolutionCo.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.4.5BiosolutionCo.RecentDevelopment
13.5BrainstormCellTherapeutics,Inc
13.5.1BrainstormCellTherapeutics,IncCompanyDetails
13.5.2BrainstormCellTherapeutics,IncBusinessOverviewandItsTotalRevenue
13.5.3BrainstormCellTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
13.5.4BrainstormCellTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.5.5BrainstormCellTherapeutics,IncRecentDevelopment
13.6MaxCyte,Inc
13.6.1MaxCyte,IncCompanyDetails
13.6.2MaxCyte,IncBusinessOverviewandItsTotalRevenue
13.6.3MaxCyte,IncCellTherapyandTissueEngineeringIntroduction
13.6.4MaxCyte,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.6.5MaxCyte,IncRecentDevelopment
13.7MedigeneAG
13.7.1MedigeneAGCompanyDetails
13.7.2MedigeneAGBusinessOverviewandItsTotalRevenue
13.7.3MedigeneAGCellTherapyandTissueEngineeringIntroduction
13.7.4MedigeneAGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.7.5MedigeneAGRecentDevelopment
13.8MEDIPOSTCO.
13.8.1MEDIPOSTCO.CompanyDetails
13.8.2MEDIPOSTCO.BusinessOverviewandItsTotalRevenue
13.8.3MEDIPOSTCO.CellTherapyandTissueEngineeringIntroduction
13.8.4MEDIPOSTCO.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.8.5MEDIPOSTCO.RecentDevelopment
13.9MesoblastLimited
13.9.1MesoblastLimitedCompanyDetails
13.9.2MesoblastLimitedBusinessOverviewandItsTotalRevenue
13.9.3MesoblastLimitedCellTherapyandTissueEngineeringIntroduction
13.9.4MesoblastLimitedRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.9.5MesoblastLimitedRecentDevelopment
13.10MiromatrixMedical,Inc.
13.10.1MiromatrixMedical,Inc.CompanyDetails
13.10.2MiromatrixMedical,Inc.BusinessOverviewandItsTotalRevenue
13.10.3MiromatrixMedical,Inc.CellTherapyandTissueEngineeringIntroduction
13.10.4MiromatrixMedical,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
13.10.5MiromatrixMedical,Inc.RecentDevelopment
13.11MolMedS.p.A
10.11.1MolMedS.p.ACompanyDetails
10.11.2MolMedS.p.ABusinessOverviewandItsTotalRevenue
10.11.3MolMedS.p.ACellTherapyandTissueEngineeringIntroduction
10.11.4MolMedS.p.ARevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.11.5MolMedS.p.ARecentDevelopment
13.12MustangBio,Inc
10.12.1MustangBio,IncCompanyDetails
10.12.2MustangBio,IncBusinessOverviewandItsTotalRevenue
10.12.3MustangBio,IncCellTherapyandTissueEngineeringIntroduction
10.12.4MustangBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.12.5MustangBio,IncRecentDevelopment
13.13NantKwest,Inc.
10.13.1NantKwest,Inc.CompanyDetails
10.13.2NantKwest,Inc.BusinessOverviewandItsTotalRevenue
10.13.3NantKwest,Inc.CellTherapyandTissueEngineeringIntroduction
10.13.4NantKwest,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.13.5NantKwest,Inc.RecentDevelopment
13.14Neuralstem,Inc
10.14.1Neuralstem,IncCompanyDetails
10.14.2Neuralstem,IncBusinessOverviewandItsTotalRevenue
10.14.3Neuralstem,IncCellTherapyandTissueEngineeringIntroduction
10.14.4Neuralstem,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.14.5Neuralstem,IncRecentDevelopment
13.15NexImmune,Inc.
10.15.1NexImmune,Inc.CompanyDetails
10.15.2NexImmune,Inc.BusinessOverviewandItsTotalRevenue
10.15.3NexImmune,Inc.CellTherapyandTissueEngineeringIntroduction
10.15.4NexImmune,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.15.5NexImmune,Inc.RecentDevelopment
13.16NohlaTherapeutics,Inc
10.16.1NohlaTherapeutics,IncCompanyDetails
10.16.2NohlaTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.16.3NohlaTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.16.4NohlaTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.16.5NohlaTherapeutics,IncRecentDevelopment
13.17ReNeuronGroupplc
10.17.1ReNeuronGroupplcCompanyDetails
10.17.2ReNeuronGroupplcBusinessOverviewandItsTotalRevenue
10.17.3ReNeuronGroupplcCellTherapyandTissueEngineeringIntroduction
10.17.4ReNeuronGroupplcRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.17.5ReNeuronGroupplcRecentDevelopment
13.18Richter-HelmBioLogicsGmbH&Co.KG
10.18.1Richter-HelmBioLogicsGmbH&Co.KGCompanyDetails
10.18.2Richter-HelmBioLogicsGmbH&Co.KGBusinessOverviewandItsTotalRevenue
10.18.3Richter-HelmBioLogicsGmbH&Co.KGCellTherapyandTissueEngineeringIntroduction
10.18.4Richter-HelmBioLogicsGmbH&Co.KGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.18.5Richter-HelmBioLogicsGmbH&Co.KGRecentDevelopment
13.19RoosterBio,Inc
10.19.1RoosterBio,IncCompanyDetails
10.19.2RoosterBio,IncBusinessOverviewandItsTotalRevenue
10.19.3RoosterBio,IncCellTherapyandTissueEngineeringIntroduction
10.19.4RoosterBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.19.5RoosterBio,IncRecentDevelopment
13.20RoslinCT
10.20.1RoslinCTCompanyDetails
10.20.2RoslinCTBusinessOverviewandItsTotalRevenue
10.20.3RoslinCTCellTherapyandTissueEngineeringIntroduction
10.20.4RoslinCTRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.20.5RoslinCTRecentDevelopment
13.21RubiusTherapeutics,Inc.
10.21.1RubiusTherapeutics,Inc.CompanyDetails
10.21.2RubiusTherapeutics,Inc.BusinessOverviewandItsTotalRevenue
10.21.3RubiusTherapeutics,Inc.CellTherapyandTissueEngineeringIntroduction
10.21.4RubiusTherapeutics,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.21.5RubiusTherapeutics,Inc.RecentDevelopment
13.22SangamoTherapeutics,Inc
10.22.1SangamoTherapeutics,IncCompanyDetails
10.22.2SangamoTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.22.3SangamoTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.22.4SangamoTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.22.5SangamoTherapeutics,IncRecentDevelopment
13.23VoyagerTherapeutics,Inc
10.23.1VoyagerTherapeutics,IncCompanyDetails
10.23.2VoyagerTherapeutics,IncBusinessOverviewandItsTotalRevenue
10.23.3VoyagerTherapeutics,IncCellTherapyandTissueEngineeringIntroduction
10.23.4VoyagerTherapeutics,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.23.5VoyagerTherapeutics,IncRecentDevelopment
13.24WaismanBiomanufacturing
10.24.1WaismanBiomanufacturingCompanyDetails
10.24.2WaismanBiomanufacturingBusinessOverviewandItsTotalRevenue
10.24.3WaismanBiomanufacturingCellTherapyandTissueEngineeringIntroduction
10.24.4WaismanBiomanufacturingRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.24.5WaismanBiomanufacturingRecentDevelopment
13.25WindMILTherapeutics,Inc.
10.25.1WindMILTherapeutics,Inc.CompanyDetails
10.25.2WindMILTherapeutics,Inc.BusinessOverviewandItsTotalRevenue
10.25.3WindMILTherapeutics,Inc.CellTherapyandTissueEngineeringIntroduction
10.25.4WindMILTherapeutics,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.25.5WindMILTherapeutics,Inc.RecentDevelopment
13.26WuxiAppTec,Inc.
10.26.1WuxiAppTec,Inc.CompanyDetails
10.26.2WuxiAppTec,Inc.BusinessOverviewandItsTotalRevenue
10.26.3WuxiAppTec,Inc.CellTherapyandTissueEngineeringIntroduction
10.26.4WuxiAppTec,Inc.RevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.26.5WuxiAppTec,Inc.RecentDevelopment
13.27ReNeuronGroupplc
10.27.1ReNeuronGroupplcCompanyDetails
10.27.2ReNeuronGroupplcBusinessOverviewandItsTotalRevenue
10.27.3ReNeuronGroupplcCellTherapyandTissueEngineeringIntroduction
10.27.4ReNeuronGroupplcRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.27.5ReNeuronGroupplcRecentDevelopment
13.28Richter-HelmBioLogicsGmbH&Co.KG
10.28.1Richter-HelmBioLogicsGmbH&Co.KGCompanyDetails
10.28.2Richter-HelmBioLogicsGmbH&Co.KGBusinessOverviewandItsTotalRevenue
10.28.3Richter-HelmBioLogicsGmbH&Co.KGCellTherapyandTissueEngineeringIntroduction
10.28.4Richter-HelmBioLogicsGmbH&Co.KGRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.28.5Richter-HelmBioLogicsGmbH&Co.KGRecentDevelopment
13.29RoosterBio,Inc
10.29.1RoosterBio,IncCompanyDetails
10.29.2RoosterBio,IncBusinessOverviewandItsTotalRevenue
10.29.3RoosterBio,IncCellTherapyandTissueEngineeringIntroduction
10.29.4RoosterBio,IncRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.29.5RoosterBio,IncRecentDevelopment
13.30RoslinCT
10.30.1RoslinCTCompanyDetails
10.30.2RoslinCTBusinessOverviewandItsTotalRevenue
10.30.3RoslinCTCellTherapyandTissueEngineeringIntroduction
10.30.4RoslinCTRevenueinCellTherapyandTissueEngineeringBusiness(2016-2021)
10.30.5RoslinCTRecentDevelopment 14Analyst'sViewpoints/Conclusions 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2Disclaimer
15.3AuthorDetails

Cell Therapy and Tissue Engineering Market Segments


Cell Therapy and Tissue Engineering Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Cell Therapy
  • Tissue Engineering

Cell Therapy and Tissue Engineering Application Outlook (Revenue, USD Million, 2021 2027)


  • Cell Defects
  • Genetic Diseases
  • Neurodegenerative Diseases
  • Tissue Malignancies
  • Others

Cell Therapy and Tissue Engineering Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Europe
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Asia Pacific
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Latin America
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

  • Middle East & Africa
    • Cell Therapy and Tissue Engineering market, By Product Type Outlook
      • Cell Therapy
      • Tissue Engineering

    • Cell Therapy and Tissue Engineering market, By Application Outlook
      • Cell Defects
      • Genetic Diseases
      • Neurodegenerative Diseases
      • Tissue Malignancies
      • Others

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables
Table 1. Cell Therapy and Tissue Engineering Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
Table 3. Ranking of Global Top Cell Therapy and Tissue Engineering Manufacturers by Revenue (US$ Million) in 2020
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 8. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2021 VS 2027
Table 9. Global Cell Therapy and Tissue Engineering Market Size by Regions (2016-2021) (US$ Million)
Table 10. Global Cell Therapy and Tissue Engineering Market Share by Regions (2016-2021)
Table 11. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 12. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2027)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cell Therapy and Tissue Engineering Market Growth Strategy
Table 17. Main Points Interviewed from Key Cell Therapy and Tissue Engineering Players
Table 18. Global Cell Therapy and Tissue Engineering Revenue by Players (2016-2021) (Million US$)
Table 19. Global Cell Therapy and Tissue Engineering Market Share by Players (2016-2021)
Table 20. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020)
Table 21. Global Cell Therapy and Tissue Engineering by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell Therapy and Tissue Engineering Product Solution and Service
Table 24. Date of Enter into Cell Therapy and Tissue Engineering Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2016-2021)
Table 28. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2021-2027)
Table 29. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2016-2021)
Table 30. Global Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 31. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2021-2027)
Table 32. North America Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 33. North America Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 34. North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 35. North America Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 36. North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 37. North America Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 38. Europe Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 39. Europe Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 41. Europe Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 42. Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 43. Europe Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 44. China Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 45. China Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 47. China Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 49. China Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 50. Japan Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 51. Japan Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 52. Japan Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 53. Japan Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 54. Japan Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 55. Japan Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 56. Southeast Asia Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 57. Southeast Asia Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 58. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 59. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 60. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 61. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 62. India Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 63. India Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 64. India Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 65. India Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 66. India Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 67. India Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 68. Central & South America Key Players Cell Therapy and Tissue Engineering Revenue (2020-2021) (Million US$)
Table 69. Central & South America Key Players Cell Therapy and Tissue Engineering Market Share (2020-2021)
Table 70. Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (Million US$)
Table 71. Central & South America Cell Therapy and Tissue Engineering Market Share by Type (2016-2021)
Table 72. Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (Million US$)
Table 73. Central & South America Cell Therapy and Tissue Engineering Market Share by Application (2016-2021)
Table 74. Betalin Therapeutics Company Details
Table 75. Betalin Therapeutics Business Overview
Table 76. Betalin Therapeutics Product
Table 77. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 78. Betalin Therapeutics Recent Development
Table 79. BioCardia, Inc Company Details
Table 80. BioCardia, Inc Business Overview
Table 81. BioCardia, Inc Product
Table 82. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 83. BioCardia, Inc Recent Development
Table 84. BioReliance Corporation Company Details
Table 85. BioReliance Corporation Business Overview
Table 86. BioReliance Corporation Product
Table 87. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 88. BioReliance Corporation Recent Development
Table 89. Biosolution Co. Company Details
Table 90. Biosolution Co. Business Overview
Table 91. Biosolution Co. Product
Table 92. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 93. Biosolution Co. Recent Development
Table 94. Brainstorm Cell Therapeutics, Inc Company Details
Table 95. Brainstorm Cell Therapeutics, Inc Business Overview
Table 96. Brainstorm Cell Therapeutics, Inc Product
Table 97. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 98. Brainstorm Cell Therapeutics, Inc Recent Development
Table 99. MaxCyte, Inc Company Details
Table 100. MaxCyte, Inc Business Overview
Table 101. MaxCyte, Inc Product
Table 102. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 103. MaxCyte, Inc Recent Development
Table 104. Medigene AG Company Details
Table 105. Medigene AG Business Overview
Table 106. Medigene AG Product
Table 107. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 108. Medigene AG Recent Development
Table 109. MEDIPOST CO. Business Overview
Table 110. MEDIPOST CO. Product
Table 111. MEDIPOST CO. Company Details
Table 112. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 113. MEDIPOST CO. Recent Development
Table 114. Mesoblast Limited Company Details
Table 115. Mesoblast Limited Business Overview
Table 116. Mesoblast Limited Product
Table 117. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 118. Mesoblast Limited Recent Development
Table 119. Miromatrix Medical, Inc. Company Details
Table 120. Miromatrix Medical, Inc. Business Overview
Table 121. Miromatrix Medical, Inc. Product
Table 122. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 123. Miromatrix Medical, Inc. Recent Development
Table 124. MolMed S.p.A Company Details
Table 125. MolMed S.p.A Business Overview
Table 126. MolMed S.p.A Product
Table 127. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 128. MolMed S.p.A Recent Development
Table 129. Mustang Bio, Inc Company Details
Table 130. Mustang Bio, Inc Business Overview
Table 131. Mustang Bio, Inc Product
Table 132. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 133. Mustang Bio, Inc Recent Development
Table 134. NantKwest, Inc. Company Details
Table 135. NantKwest, Inc. Business Overview
Table 136. NantKwest, Inc. Product
Table 137. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 138. NantKwest, Inc. Recent Development
Table 139. Neuralstem, Inc Company Details
Table 140. Neuralstem, Inc Business Overview
Table 141. Neuralstem, Inc Product
Table 142. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 143. Neuralstem, Inc Recent Development
Table 144. NexImmune, Inc. Company Details
Table 145. NexImmune, Inc. Business Overview
Table 146. NexImmune, Inc. Product
Table 147. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 148. NexImmune, Inc. Recent Development
Table 149. Nohla Therapeutics, Inc Company Details
Table 150. Nohla Therapeutics, Inc Business Overview
Table 151. Nohla Therapeutics, Inc Product
Table 152. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 153. Nohla Therapeutics, Inc Recent Development
Table 154. ReNeuron Group plc Company Details
Table 155. ReNeuron Group plc Business Overview
Table 156. ReNeuron Group plc Product
Table 157. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 158. ReNeuron Group plc Recent Development
Table 159. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 160. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 161. Richter-Helm BioLogics GmbH & Co. KG Product
Table 162. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 163. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 164. RoosterBio, Inc Company Details
Table 165. RoosterBio, Inc Business Overview
Table 166. RoosterBio, Inc Product
Table 167. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 168. RoosterBio, Inc Recent Development
Table 169. RoslinCT Company Details
Table 170. RoslinCT Business Overview
Table 171. RoslinCT Product
Table 172. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 173. RoslinCT Recent Development
Table 174. Rubius Therapeutics, Inc. Company Details
Table 175. Rubius Therapeutics, Inc. Business Overview
Table 176. Rubius Therapeutics, Inc. Product
Table 177. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 178. Rubius Therapeutics, Inc. Recent Development
Table 179. Sangamo Therapeutics, Inc Company Details
Table 180. Sangamo Therapeutics, Inc Business Overview
Table 181. Sangamo Therapeutics, Inc Product
Table 182. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 183. Sangamo Therapeutics, Inc Recent Development
Table 184. Voyager Therapeutics, Inc Company Details
Table 185. Voyager Therapeutics, Inc Business Overview
Table 186. Voyager Therapeutics, Inc Product
Table 187. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 188. Voyager Therapeutics, Inc Recent Development
Table 189. Waisman Biomanufacturing Company Details
Table 190. Waisman Biomanufacturing Business Overview
Table 191. Waisman Biomanufacturing Product
Table 192. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 193. Waisman Biomanufacturing Recent Development
Table 194. WindMIL Therapeutics, Inc. Company Details
Table 195. WindMIL Therapeutics, Inc. Business Overview
Table 196. WindMIL Therapeutics, Inc. Product
Table 197. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 198. WindMIL Therapeutics, Inc. Recent Development
Table 199. Wuxi App Tec, Inc. Company Details
Table 200. Wuxi App Tec, Inc. Business Overview
Table 201. Wuxi App Tec, Inc. Product
Table 202. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 203. Wuxi App Tec, Inc. Recent Development
Table 204. ReNeuron Group plc Company Details
Table 205. ReNeuron Group plc Business Overview
Table 206. ReNeuron Group plc Product
Table 207. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 208. ReNeuron Group plc Recent Development
Table 209. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 210. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 211. Richter-Helm BioLogics GmbH & Co. KG Product
Table 212. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 213. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 214. RoosterBio, Inc Company Details
Table 215. RoosterBio, Inc Business Overview
Table 216. RoosterBio, Inc Product
Table 217. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 218. RoosterBio, Inc Recent Development
Table 219. RoslinCT Company Details
Table 220. RoslinCT Business Overview
Table 221. RoslinCT Product
Table 222. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) (Million US$)
Table 223. RoslinCT Recent Development
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2021 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2021 VS 2027
Figure 5. Cell Defects Case Studies
Figure 6. Genetic Diseases Case Studies
Figure 7. Neurodegenerative Diseases Case Studies
Figure 8. Tissue Malignancies Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy and Tissue Engineering Report Years Considered
Figure 11. Global Cell Therapy and Tissue Engineering Market Size YoY Growth 2016-2027 (US$ Million)
Figure 12. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2021 VS 2027
Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2027)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2020
Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2020
Figure 18. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 19. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 20. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 21. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 22. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 23. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 24. Central & South America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2021) (Million US$)
Figure 25. Betalin Therapeutics Total Revenue (US$ Million): 2020 Compared with 2018
Figure 26. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 27. BioCardia, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 28. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 29. BioReliance Corporation Total Revenue (US$ Million): 2020 Compared with 2018
Figure 30. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 31. Biosolution Co. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 32. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 33. Brainstorm Cell Therapeutics, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 34. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 35. MaxCyte, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 36. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 37. Medigene AG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 38. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 39. MEDIPOST CO. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 40. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 41. Mesoblast Limited Total Revenue (US$ Million): 2020 Compared with 2018
Figure 42. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 43. Miromatrix Medical, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 44. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 45. MolMed S.p.A Total Revenue (US$ Million): 2020 Compared with 2018
Figure 46. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 47. Mustang Bio, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 48. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 49. NantKwest, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 50. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 51. Neuralstem, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 52. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 53. NexImmune, Inc. Total Revenue (US$ Million): 2020 Compared with 2018
Figure 54. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 55. Nohla Therapeutics, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 56. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 57. ReNeuron Group plc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 58. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 59. Richter-Helm BioLogics GmbH & Co. KG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 60. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 61. RoosterBio, Inc Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 63. RoslinCT Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Protective Eyewear Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Smart Orthopedic Implants Market

Report Description The Global Smart Orthopedic Implants Market Report provides Insightful informatio

Read More

Biotechnology Reagents & Kits Market

Report Description The Global Biotechnology Reagents & Kits Market Report provides Insightful inform

Read More